Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0GW6K
|
|||
| Former ID |
DNCL003084
|
|||
| Drug Name |
ADX N05
|
|||
| Indication | Mood disorder [ICD-11: 6A60-6E23] | Phase 3 | [1] | |
| Excessive daytime sleepiness [ICD-11: MG42; ICD-10: F51.1, G47.1] | Phase 2 | [1] | ||
| Company |
Aerial BioPharma
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Opioid receptor sigma 1 (OPRS1) | Target Info | Modulator | [2] |
| WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030225) | |||
| REF 2 | Clinical pipeline report, company report or official report of SK BioPhamaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.